"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
Descriptor ID |
D018450
|
MeSH Number(s) |
C23.550.291.656
|
Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 4 | 4 |
1996 | 0 | 10 | 10 |
1997 | 0 | 4 | 4 |
1998 | 0 | 10 | 10 |
1999 | 0 | 7 | 7 |
2000 | 0 | 16 | 16 |
2001 | 0 | 16 | 16 |
2002 | 0 | 18 | 18 |
2003 | 0 | 21 | 21 |
2004 | 0 | 35 | 35 |
2005 | 0 | 34 | 34 |
2006 | 0 | 46 | 46 |
2007 | 1 | 33 | 34 |
2008 | 0 | 39 | 39 |
2009 | 3 | 50 | 53 |
2010 | 3 | 45 | 48 |
2011 | 3 | 49 | 52 |
2012 | 2 | 58 | 60 |
2013 | 2 | 46 | 48 |
2014 | 4 | 52 | 56 |
2015 | 6 | 62 | 68 |
2016 | 3 | 52 | 55 |
2017 | 7 | 57 | 64 |
2018 | 10 | 67 | 77 |
2019 | 4 | 62 | 66 |
2020 | 4 | 51 | 55 |
2021 | 5 | 36 | 41 |
2022 | 1 | 23 | 24 |
2023 | 0 | 38 | 38 |
2024 | 11 | 16 | 27 |
2025 | 1 | 11 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
ACR Appropriateness Criteria® Lung Cancer-Surveillance After Therapy. J Am Coll Radiol. 2025 May; 22(5S):S319-S342.
-
Global evolution of inflammatory bowel disease across epidemiologic stages. Nature. 2025 Jun; 642(8067):458-466.
-
Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung Volumes. Ann Am Thorac Soc. 2025 Apr; 22(4):494-505.
-
Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to Action. JAMA Cardiol. 2025 Apr 01; 10(4):391-398.
-
Recommended Clinical Context and Patient Context Data Elements for Liquid Biopsy Data Submitted to Data Repositories and Data Commons. Clin Transl Sci. 2025 Apr; 18(4):e70227.
-
Home-Based Tele-tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy. Ann Clin Transl Neurol. 2025 May; 12(5):1022-1033.
-
Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of Ataxia. Mov Disord. 2025 May; 40(5):917-927.
-
Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort. Alzheimers Dement. 2025 Mar; 21(3):e70075.
-
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis. JACC Cardiovasc Interv. 2025 Mar 24; 18(6):738-748.
-
Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICS. Am J Respir Crit Care Med. 2025 Feb; 211(2):215-221.